| |
| |
|
| Insider
Information: |
Brennan Daniel J. |
| Relationship: |
Director |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
272,248 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,358,775 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
272,248 |
|
|
| Total
Value |
$20,358,775 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 8.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP and CFO |
2024-02-20 |
271,542 |
|
0 |
Premium* |
|
|
Nuance Communications Inc |
NUAN |
Director |
2022-03-04 |
0 |
2018-09-10 |
0 |
Premium* |
|
|
Waters Corp |
WAT |
Director |
2024-01-02 |
706 |
2022-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2024-02-14 |
4 |
D |
$65.95 |
$127,613 |
D/D |
(1,935) |
264,569 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2024-02-20 |
4 |
S |
$65.86 |
$899,779 |
D/D |
(13,662) |
271,542 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2024-02-16 |
4 |
D |
$65.82 |
$123,873 |
D/D |
(1,882) |
266,930 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2024-02-17 |
4 |
D |
$65.82 |
$133,812 |
D/D |
(2,033) |
269,480 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2024-02-18 |
4 |
D |
$65.82 |
$108,208 |
D/D |
(1,644) |
271,542 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2024-01-01 |
4 |
D |
$57.81 |
$473,984 |
D/D |
(8,199) |
241,738 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2023-02-15 |
4 |
D |
$47.29 |
$57,647 |
D/D |
(1,219) |
283,888 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2023-02-15 |
4 |
AS |
$47.14 |
$356,927 |
D/D |
(7,572) |
276,316 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2023-03-02 |
4 |
AS |
$46.66 |
$1,399,914 |
D/D |
(30,000) |
225,958 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2023-03-01 |
4 |
AS |
$46.64 |
$3,526,337 |
D/D |
(75,610) |
255,958 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2023-02-17 |
4 |
D |
$46.54 |
$94,616 |
D/D |
(2,033) |
281,859 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2023-02-18 |
4 |
D |
$46.54 |
$76,512 |
D/D |
(1,644) |
283,921 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2023-02-16 |
4 |
D |
$46.48 |
$58,100 |
D/D |
(1,250) |
279,309 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2023-01-01 |
4 |
D |
$46.27 |
$187,023 |
D/D |
(4,042) |
273,382 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2023-02-21 |
4 |
D |
$46.23 |
$75,078 |
D/D |
(1,624) |
285,958 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-01-01 |
4 |
D |
$45.22 |
$297,457 |
D/D |
(6,578) |
230,247 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2022-02-28 |
4 |
D |
$44.17 |
$87,810 |
D/D |
(1,988) |
275,319 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2022-03-02 |
4 |
AS |
$44.03 |
$485,650 |
D/D |
(11,029) |
264,290 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2022-02-15 |
4 |
D |
$44.01 |
$53,648 |
D/D |
(1,219) |
275,313 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2022-02-16 |
4 |
AS |
$43.70 |
$532,580 |
D/D |
(12,187) |
266,177 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2022-02-15 |
4 |
AS |
$43.47 |
$397,142 |
D/D |
(9,136) |
266,177 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2022-02-17 |
4 |
D |
$42.83 |
$87,073 |
D/D |
(2,033) |
268,727 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2022-02-22 |
4 |
AS |
$42.75 |
$2,273,621 |
D/D |
(53,182) |
272,826 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-21 |
4 |
D |
$42.62 |
$70,749 |
D/D |
(1,660) |
254,697 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP and CFO |
• • – |
2020-02-22 |
4 |
D |
$42.62 |
$112,005 |
D/D |
(2,628) |
257,863 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
